PMID- 38058978
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20240312
IS  - 2473-0114 (Electronic)
IS  - 2473-0114 (Linking)
VI  - 8
IP  - 4
DP  - 2023 Oct
TI  - Utilization of PROMIS Neuropathic Pain Quality for Detection and Monitoring 
      Neuropathic Pain in Heel Pain Patients.
PG  - 24730114231213620
LID - 10.1177/24730114231213620 [doi]
LID - 24730114231213620
AB  - BACKGROUND: Diagnosis and management of neuropathic pain (NP) in foot and ankle 
      patients remain challenging. We investigated the plausibility of using 
      Patient-Reported Outcomes Measurement Information System (PROMIS) Neuropathic 
      Pain Quality (PQ-Neuro) as an initial screening tool to detect NP and track the 
      treatment effects. METHODS: Patients with heel pain were prospectively recruited 
      and grouped to no-NP, mild-NP, and severe-NP based on the initial PROMIS PQ-Neuro 
      t scores. Pain Interference (PI), Physical Function (PF), and Self-Efficacy (SE) 
      scores were evaluated at baseline, 30-day, and 90-day follow-up. Other factors 
      such as age, smoking, body mass index (BMI), low back/neck pain, 
      anxiety/depression, and medications were analyzed. Linear mixed modeling was used 
      to assess the main effects of time and NP on PROMIS t scores, comparing minimal 
      clinically important difference (MCID). RESULTS: Forty-eight patients with mean 
      age of 52.4 years were recruited. Using the PROMIS PQ-Neuro as the assessment 
      tool, 33 patients (69%) were detected to have NP at baseline-23 (48%) mild and 10 
      (21%) severe. BMI was the only independent factor associated with NP (P = .011). 
      Higher baseline PQ-Neuro t score was significantly associated with higher 
      follow-up PQ-Neuro (P < .001), PI (P = .005), and lower SE (P = .04) across time 
      points. Patients with NP showed lower PF at baseline with significantly less 
      improvement in PF (3 vs 9.9, P = .035) and did not meet MCID. CONCLUSION: 
      Baseline PROMIS PQ-Neuro >/=46 was significantly associated with worse PI and SE 
      across all time points, with less clinically significant improvements in PF. 
      Prevalence of NP in heel pain patients was high. The PROMIS PQ-Neuro may serve as 
      a valuable tool for detection of NP and guiding clinical treatment decision 
      pathways for heel pain patients. LEVEL OF EVIDENCE: Level III, prospective cohort 
      study.
CI  - (c) The Author(s) 2023.
FAU - Joo, Peter Y
AU  - Joo PY
AUID- ORCID: 0000-0003-4370-0720
AD  - Department of Orthopaedics and Rehabilitation, University of Rochester Medical 
      Center, Rochester, NY, USA.
AD  - Department of Orthopaedics and Rehabilitation, Yale School of Medicine, New 
      Haven, CT, USA.
FAU - Lee, Wonyong
AU  - Lee W
AD  - Department of Orthopaedic Surgery, Guthrie Clinic, Sayre, PA, USA.
FAU - Hoffman, Samantha
AU  - Hoffman S
AD  - Department of Orthopaedics and Rehabilitation, University of Rochester Medical 
      Center, Rochester, NY, USA.
FAU - Baumhauer, Judith
AU  - Baumhauer J
AUID- ORCID: 0000-0003-2142-7778
AD  - Department of Orthopaedics and Rehabilitation, University of Rochester Medical 
      Center, Rochester, NY, USA.
FAU - Oh, Irvin
AU  - Oh I
AD  - Department of Orthopaedics and Rehabilitation, University of Rochester Medical 
      Center, Rochester, NY, USA.
AD  - Department of Orthopaedics and Rehabilitation, Yale School of Medicine, New 
      Haven, CT, USA.
LA  - eng
GR  - UL1 TR001863/TR/NCATS NIH HHS/United States
PT  - Journal Article
DEP - 20231204
PL  - United States
TA  - Foot Ankle Orthop
JT  - Foot & ankle orthopaedics
JID - 101752333
PMC - PMC10697051
OTO - NOTNLM
OT  - BMI
OT  - PROMIS
OT  - PROMIS neuropathic pain quality
OT  - heel pain
OT  - neuropathic pain
COIS- The author(s) declared no potential conflicts of interest with respect to the 
      research, authorship, and/or publication of this article. ICMJE forms for all 
      authors are available online.
EDAT- 2023/12/07 06:42
MHDA- 2023/12/07 06:43
PMCR- 2023/12/04
CRDT- 2023/12/07 04:12
PHST- 2023/12/07 06:43 [medline]
PHST- 2023/12/07 06:42 [pubmed]
PHST- 2023/12/07 04:12 [entrez]
PHST- 2023/12/04 00:00 [pmc-release]
AID - 10.1177_24730114231213620 [pii]
AID - 10.1177/24730114231213620 [doi]
PST - epublish
SO  - Foot Ankle Orthop. 2023 Dec 4;8(4):24730114231213620. doi: 
      10.1177/24730114231213620. eCollection 2023 Oct.